{"filing":{"accession_number":"0001104659-26-073517","cik":"0002006986","ticker":"ADGM","company_name":"Adagio Medical Holdings, Inc.","form":"8-K","filing_date":"2026-06-12","report_date":null,"primary_document":"tm2617882d1_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/2006986/000110465926073517/tm2617882d1_8k.htm"},"events":[{"id":10301,"run_id":9035,"accession_number":"0001104659-26-073517","anchor_item_number":"3.01","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.98,"summary":"Adagio Medical received a notice from Nasdaq on June 12, 2026, that its common stock failed to comply with Nasdaq Listing Rule 5550(a)(2) due to a minimum bid price below $1.00 per share for 30 consecutive business days. The Company has 180 calendar days until December 9, 2026, to regain compliance, with a potential second 180-day period available if certain conditions are met. Failure to regain compliance will result in delisting notification. This is a material disclosure of delisting risk under Item 3.01.","company_name":"Adagio Medical Holdings, Inc.","ticker":"ADGM","filing_date":"2026-06-12","submitted_at":null,"items":[{"id":6587,"accession_number":"0001104659-26-073517","item_number":"3.01","item_title":"Notice of Delisting or Failure to Satisfy a Continued","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.98,"reasoning":"Adagio Medical received a notice from Nasdaq on June 12, 2026, that its common stock failed to comply with Nasdaq Listing Rule 5550(a)(2) due to a minimum bid price below $1.00 per share for 30 consecutive business days. The Company has 180 calendar days until December 9, 2026, to regain compliance, with a potential second 180-day period available if certain conditions are met. Failure to regain compliance will result in delisting notification. This is a material disclosure of delisting risk under Item 3.01.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-13T00:01:47.758611+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":6587,"accession_number":"0001104659-26-073517","item_number":"3.01","item_title":"Notice of Delisting or Failure to Satisfy a Continued","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.98,"reasoning":"Adagio Medical received a notice from Nasdaq on June 12, 2026, that its common stock failed to comply with Nasdaq Listing Rule 5550(a)(2) due to a minimum bid price below $1.00 per share for 30 consecutive business days. The Company has 180 calendar days until December 9, 2026, to regain compliance, with a potential second 180-day period available if certain conditions are met. Failure to regain compliance will result in delisting notification. This is a material disclosure of delisting risk under Item 3.01.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-13T00:01:47.758611+00:00","company_name":"Adagio Medical Holdings, Inc.","ticker":"ADGM","filing_date":"2026-06-12"}]}